The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

US STOCKS-Wall St ends near flat after recent gains; healthcare climbs

Mon, 13th May 2013 20:42

* Core U.S. retail sales rise 0.5 percent in April

* Yum Brands falls as monthly Chinese sales drop

* Indexes: Dow down 0.2 pct, S&P flat, Nasdaq up 0.1 pct

By Caroline Valetkevitch

NEW YORK, May 13 (Reuters) - U.S. stocks ended flat onMonday, pausing after hitting record highs last week, butstrength in healthcare issues helped to keep declines in check.

The S&P 500 healthcare sector climbed 0.7 percentand was the day's best performer.

Shares of Theravance jumped 17.9 percent to $41.20after Irish drugmaker Elan agreed to a $1billion deal to buy 21 percent of the royalties that Theravancereceives from GlaxoSmithKline for itsrespiratory drugs.

The day's flat activity follows a third straight week ofgains on the major indexes, with both the Dow and S&P 500setting record closing highs last week. The S&P 500 remains up14.5 percent for the year so far.

While some analysts argue the long-term trend is stillhigher, many see momentum waning in the near term in the absenceof positive catalysts. Volume has been lighter than average, andvolatility has been low in recent days.

"Intraday volatility has essentially been nonexistent. Ithink it means people are really sitting on the sidelines rightnow seeing which way it's going to go," said Uri Landesman,president of Platinum Partners in New York.

The CBOE Volatility index ended down 0.3 percent.

The Dow Jones industrial average was down 26.81points, or 0.18 percent, at 15,091.68. The Standard & Poor's 500Index was up 0.07 points at 1,633.77. The NasdaqComposite Index was up 2.21 points, or 0.06 percent, at3,438.79.

Among the day's decliners, Yum Brands Inc fell 2percent to $68.92. After the market closed on Friday, the fastfood chain operator posted a steep decline in Chinese Aprilsales.

Helping to limit the market's downside, retail sales rose0.1 percent in April, better than the 0.3 percent drop that hadbeen expected, and returning to growth following a decline inMarch. Excluding autos, gasoline and buildingmaterials, core sales rose 0.5 percent. Retail sales account forabout 30 percent of U.S. consumer spending.

Investors are at odds over whether positive economic datacan help the market rise further, or whether it will spell theend of the Federal Reserve's monetary stimulus, which couldderail the rally, said Joseph Tanious, global market strategistat J.P. Morgan Funds.

Other data showed business inventories were unchanged inMarch for a second straight month, versus expectations of 0.3percent rise, suggesting restocking could help second-quartereconomic growth.

Earnings have been mostly better than expected. With 90percent of the S&P 500 having reported, 67.2 percent ofcompanies have topped earnings expectations, according toThomson Reuters data, even with the average over the past fourquarters. Only 46.9 percent have beaten revenue expectations,below the 52 percent average over the past four quarters.

U.S.-listed shares of Perion Network surged 10.6percent to $13.94 after the Israeli consumer Internet companyposted first-quarter earnings.

More News
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.